Trial intelligence / Profile preview

Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus

IRCT138710291562N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sodium cromoglycate in chronic kidney disease-associated pruritus (CKD-aP), sponsored by Shiraz University of Medical Sciences. Started Aug 2008; status: completed.

02

Drugs

sodium cromoglycate
03

Conditions

chronic kidney disease-associated pruritus (CKD-aP)

Beyond the preview

Go deeper on IRCT138710291562N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138710291562N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call